FIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS

Similar documents
Glomerular diseases with organized deposits

Monoclonal Gammopathies and the Kidney. Tibor Nádasdy, MD The Ohio State University, Columbus, OH

Pathology of Complement Mediated Renal Disease

Interesting case seminar: Native kidneys Case Report:

Surgical Pathology Report

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

C1q nephropathy the Diverse Disease

Case 3. ACCME/Disclosure. Laboratory results. Clinical history 4/13/2016

RENAL EVENING SPECIALTY CONFERENCE

Case Report A Case of Proliferative Glomerulonephritis with Monoclonal IgG Deposits That Showed Predominantly Membranous Features

C3G An Update What is C3 Glomerulopathy Anyway? Patrick D. Walker, M.D. Nephropath Little Rock, Arkansas USA

Glomerular pathology-2 Nephritic syndrome. Dr. Nisreen Abu Shahin

Glomerular Pathology- 1 Nephrotic Syndrome. Dr. Nisreen Abu Shahin

Case Presentation Turki Al-Hussain, MD

Glomerular diseases mostly presenting with Nephritic syndrome

CASE 3 AN UNUSUAL CASE OF NEPHROTIC SYNDROME

A Case of IgG2 Heavy Chain Deposition Disease in a Patient with Kappa Positive Plasma Cell Dyscrasia

Rituximab treatment for fibrillary glomerulonephritis

Case Presentation Turki Al-Hussain, MD

Article. Laser Microdissection and Proteomic Analysis of Amyloidosis, Cryoglobulinemic GN, Fibrillary GN, and Immunotactoid Glomerulopathy

Dr Ian Roberts Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

Journal of Nephropathology

Glomerular pathology in systemic disease

A clinical syndrome, composed mainly of:

Amyloidosis is caused by extracellular deposition of

Renal Pathology 1: Glomerulus. With many thanks to Elizabeth Angus PhD for EM photographs

Nephrotic syndrome minimal change disease vs. IgA nephropathy. Hadar Meringer Internal medicine B Sheba

Mayo Clinic/ RPS Consensus Report on Classification, Diagnosis, and Reporting of Glomerulonephritis

Clinical and pathological characteristics of patients with glomerular diseases at a university teaching hospital: 5-year prospective review

Familial DDD associated with a gain-of-function mutation in complement C3.

Ordering Physician. Collected REVISED REPORT. Performed. IgG IF, Renal MCR. Lambda IF, Renal MCR. C1q IF, Renal. MCR Albumin IF, Renal MCR

substance staining with IgG, C3 and IgA (trace) Linear deposition of IgG(+), IgA.M(trace) and C3(+++) at the DEJ

Clinicopathological analysis of proliferative glomerulonephritis with monoclonal IgG deposits in 5 renal allografts

C3 GLOMERULOPATHIES. Budapest Nephrology School Zoltan Laszik

Overview of glomerular diseases

Secondary IgA Nephropathy & HSP

Case Report Nephrotic Syndrome Secondary to Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits of Lambda Light Chain

Sheena Surindran Grand Rounds 2/15/11

RENAL HISTOPATHOLOGY

Rejection or Not? Interhospital Renal Meeting 10 Oct Desmond Yap & Sydney Tang Queen Mary Hospital

CHAPTER 2 PRIMARY GLOMERULONEPHRITIS

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST

Clinical history. 73 yo man with chest pain Systemic hypertension and WG Stress EKG N Stress echocardiogram: Cardiac catheterization: no CAD

Complement in vasculitis and glomerulonephritis. Andy Rees Clinical Institute of Pathology Medical University of Vienna

Tuesday Conference 7/23/2013. Hasan Fattah

Index. electron microscopy, 81 immunofluorescence microscopy, 80 light microscopy, 80 Amyloidosis clinical setting, 185 etiology/pathogenesis,

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT

Classification of Glomerular Diseases and Defining Individual Glomerular Lesions: Developing International Consensus

Atypical IgA Nephropathy

IgA nephropathy: unusual forms

CHAPTER 2. Primary Glomerulonephritis

C3 Glomerulonephritis versus C3 Glomerulopathies?

Diabetic Nephropathy. Introduction/Clinical Setting. Pathologic Findings Light Microscopy. J. Charles Jennette

What s hiding behind IgA nephropathy?

Renal manifestations of IgG4-related systemic disease

A case of heavy chain deposition disease complicated by acquired angioedema.

Expanding Spectrum of Diseases Associated with Plasma Cell Dyscrasias

Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis

A Case of Immunotactoid Glomerulopathy with Rapid Progression to End-Stage Renal Disease

Jon Von Visger 1, Clarissa Cassol 2, Uday Nori 1, Gerardo Franco-Ahumada 1, Tibor Nadasdy 2 and Anjali A. Satoskar 2*

Amyloidosis is a generic term for a group of diseases

Case # 2 3/27/2017. Disclosure of Relevant Financial Relationships. Clinical history. Clinical history. Laboratory findings

Proliferative Glomerulonephritis with Monoclonal IgG Deposits Recurs in the Allograft

Glomerulonephritis. Dr Rodney Itaki Anatomical Pathology Discipline.

Histopathology: Glomerulonephritis and other renal pathology

Monoclonal gammopathies consist of. Monoclonal GammopathyeAssociated Proliferative Glomerulonephritis REVIEW

Jo Abraham MD Division of Nephrology University of Utah

EDEMA IN A PATIENT WITH RECURRENT RESPIRATORY INFECTIONS - Case Report

Update on Treatments for Systemic Amyloidosis

Comparison of amyloid deposition in human kidney biopsies as predictor of poor patient outcome

J Nephropharmacol. 2014; 3(2): Journal of Nephropharmacology

29th Annual Meeting of the Glomerular Disease Collaborative Network

GOODPASTURE'S SYNDROME WITH CONCOMITANT IMMUNE COMPLEX MIXED MEMBRANOUS AND PROLIFERATIVE GLOMERULONEFRITIS

ACCME/Disclosure. Case #1. Case History. Dr. Bracamonte has nothing to disclose

Multiple Myeloma Advances for clinical pathologists & histopathologists

Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis

CJASN epress. Published on September 28, 2010 as doi: /CJN

Tarek ElBaz, MD. Prof. Internal Medicine Chief, Division of Renal Medicine Al Azhar University President, ESNT

DIABETIC NEPHROPATHY is a major

IgA Nephropathy - «Maladie de Berger»

PATTERNS OF RENAL INJURY

Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis

HRZZ project: Genotype-Phenotype correlation in Alport's syndrome and Thin Glomerular Basement Membrane Nephropathy. Patohistological Aspects

Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis

Proliferative Glomerulonephritis with Monoclonal IgG Deposits

Dense deposit disease with steroid pulse therapy

Yijuan Sun, Amarpreet Sandhu, Darlene Gabaldon, Jonathan Danaraj, Karen S. Servilla, and Antonios H. Tzamaloukas

MICROSCOPIC HEMATURIA AND DIFFUSE NECROTIZING GLOMERULONEPHRITIS

Case Report A Clinical and Pathological Variant of Acute Transplant Glomerulopathy

Clinicopathologic Characteristics of IgA Nephropathy with Steroid-responsive Nephrotic Syndrome

Nephrology Grand Rounds. Mansi Mehta November 24, 2015

Glomerular Diseases. Anna Vinnikova, MD Nephrology

Original. IgAN. Key words : IgA nephropathy, IgM deposition, proteinuria, tonsillectomy, steroid pulse therapy. Introduction

ESRD Dialysis Prevalence - One Year Statistics

An unusual association between focal segmental sclerosis and lupus nephritis: a distinct concept from lupus podocytopathy?

Membranoproliferative Glomerulonephritis

C1q nephropathy: a true immune complex disease or an immunologic epiphenomenon?

Management of Rejection

considered for patients with cryoglobulinemic kidney diseases. (Weak)

Immunotactoid glomerulopathy: clinicopathologic and proteomic study

Transcription:

FIBRILLARY GLOMERULONEPHRITIS DIAGNOSTIC CRITERIA, PITFALLS, AND DIFFERENTIAL DIAGNOSIS Guillermo A. Herrera MD Louisiana State University, Shreveport

Fibrils in bundles 10-20 nm d Diabetic fibrillosis

SILVER METHENAMINE STAIN

SEEN IN A CHILD 10 Y/O PROTEINURIA IS OFTEN SEVERE / 70% WITH HYPERTENSION ROUGHLY HALF OF THE PATIENTS TO ESRD WITHIN 2 YEARS AFTER DIAGNOSIS

CLINICAL INFORMATION Mean age at diagnosis= 53 years Majority 95% caucasian patients Female to male ratio 1.2:1 PRESENTATION: PROTEINURIA- 100% (maybe massive), NEPHROTIC SYNDROME- 38%, RENAL INSUFFICIENCY- 66%, HEMATURIA- 52%, AND HYPERTENSION- 71% / few cases rapidly progressive renal disease Underlying diseases- malignancies- MOST COMMON CARCINOMA 23%, dysproteinemia- 17% and autoimmune diseases 15% of all patients in series Nasr, et al: Fibrillary glomerulonephritis: A report of 66 cases from a single institution. Clin J Am Soc Nephrol 6: 775-784, 2011

Light microscopy, IF, AND EM Varied morphologic patterns by LM MOST COMMON- Mesangial proliferative / sclerosing features followed by membranoproliferative in some cases mimics amyloidosis OR MEMBRANOUS NEPHROPATHY- CRESCENTS IN SOME CASES FINAL DIAGNOSIS MADE ULTRASTRUCTURALLY BUT IF PATTERN CAN BE DIAGNOSTIC (or highly suggestive)

A B

FIBRILLARY GN LIGHT MICROSCOPIC FINDINGS Can be confused with membranous GN, mesangial proliferative and membrano proliferative GN, focal proliferative, and amyloidosis Crescents are seen in 25-33% of fibrillary GN cases, and; therefore, it can also be confused with crescentic GN.

A IgG B

IMMUNOFLUORESCENCE Smudgy staining for IgG, C3, kappa and lambda light chains in most cases along peripheral capillary walls and / or in mesangium / IgA-IgM rare & small amounts C1q also rarely seen- but may be found in a few cases IgG 4 is the dominant IgG in the great majority of the cases (IgG1 in some cases) AMYLOID P COMPONENT (SAP) PRESENT- may play a role in fibrillogenesis APO-E PRESENT AS IN AMYLOID

IF FOR IgG

A B

ELECTRON MICROSCOPY Characteristic fibrils which are randomly disposed, non-branching, and typically measure 10-25 nm in diameter FIBRILS IN MESANGIUM AND IN MOST CASES ALSO ALONG PERIPHERAL CAPILLARY WALLS SIMILAR APPEARANCE TO AMYLOID BUT SIGNIFICANTLY THICKER

AMYLOID FIBRILLARY GN

A B

FIBRILLARY GN PATHOGENESIS Most likely a result of polymerization of immune complexes and, possibly monoclonal light chains in some cases Role that amyloid-p component plays still unclear but may be significant The fact that a particular IgG (IgG4) is dominant in many (?all- some IgG1) of the cases probably represents an important pathogenetic consideration HIGHLY STRUCTURED IMMUNE COMPLEXES

FIBRILLARY GN TREATMENT RENIN ANGIOTENSIN SYSTEM BLOCKADE (ACE inhibitors) STEROIDS ADDITIONAL IMMUNOSUPPRESANTS SUCH AS CYTOXAN / MMF S/T combined RITUXIMAB IN COMBINATION WITH STEROIDS OR ALONE IMMUNOMODULATION

FIBRILLARY GN OTHER IMPORTANT FACTS Mostly a renal limited disorder Thioflavin T may be very rarely positive and be confused with amyloidosis / However these cases are Congo red negative Diverse glomerular morphology Membranous variant can also be confusingoften kappa restricted (r/o underlying lymphoproliferative disorder) Diabetic fibrillosis may be an important differential diagnosis in patients with diabetic nephropathy

FIBRILLARY GN PROGNOSIS Average follow-up- 52.3 months of 61 patients 13% complete or partial remission 43% persistent renal dysfunction 44% progressed to ESRD recurrence in 36% of 14 patients with renal transplants PREDICTORS OF ESRD- Older age, higher serum creatinine and proteinuria at the time of biopsy Nasr et al: Clin J Am Soc Nephrol. 6: 775-784, 2011

FIBRILLARY GN AND RENAL TRANSPLANTATION 15 TRANSPLANTED KIDNEYS IN 12 PATIENTS Group 1-5 patients WITH FIB GN alone Group 2-7 patients WITH FIB GN AND MONOCLONAL GAMMOPATHY RECURRENCE DID NOT OCCUR IN GROUP 1 BUT DEVELOPED IN 5 kidneys OF patients from GROUP 2 7 allografts failed- 1 in Group 1 (graft thromboembolism) and 6 in Group 2. Czarnecki et al: Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or mononclonal gammopathy with fibrillary deposits. Kid Int 75: 420-427, 2009

DIFFERENTIAL DIAGNOSIS

FIBRILLARY GN DIFFERENTIAL DIAGNOSIS Membranous GN- when only IF available Amyloidosis Immunotactoid glomerulopathy Diabetic fibrillosis Fibrillary collagen

AMYLOIDOSIS Systemic disorder Involvement of all 3 renal compartments Congo red / Thioflavin T positive More than 30 amyloid precursor proteins IF- addresses light and heavy chains / fibrinogen IH- AA amyloidosis, β2 microglobulin, calcitonin, LEC-2 and so forth Stains for serum amyloid protein and Apo E Can be confused with hyalinosis (especially vascular)

A B

A B THIOFLAVIN T

Thioflavin T

AMYLOID VIEWED UNDER TEXAS RED FLUORESCENCE GATE

A B

DIAGNOSIS OF AMYLOIDOSIS IS MADE THEN WHAT?? DETERMINING TYPE OF AMYLOID look for light and heavy chain monoclonality- IF evaluate fibrinogen IF stain perform pertinent immunohistochemical stains ie. AA protein, B-2 microglobulin, calcitonin, transthyretin, lactoferrin, lysozyme and so forth* PROBLEMS: DIFFICULTY IDENTIFYING HEREDITARY AMYLOIDOSES AND SOME ABNORMAL LIGHT CHAINS DEPOSITED IN TISSUES *TYPE OF AMYLOID IDENTIFIED IN 92% OF THE CASES (formalin fixed and paraffin embedded) IN SURGICAL PATHOLOGY SPECIMENS. Kebbel and Rocken Am J Surg Pathol 2006; 30:673-683.

AMYLOID-A PROTEIN IH

Heavy chain amyloidosis AH-amyloidosis Only a handful of cases reported (one with ultrastructural labeling) Most gamma HC-associated Similar light and EM features as other amyloidoses Pathogenesis unclear

LIGHT AND HEAVY CHAIN AMYLOIDOSIS (AL/AH) 16 patients with AL/AH amyloidosis Typing using laser microdissection and mass spectroscopy (LMD/MS) (12) and by IF (4) Median age at biopsy- 63 All caucasian WHEN COMPARED WITH AL-AMYLOIDOSIS Less cardiac involvement Higher incidence of hematuria Better survival 42% of patients could have been diagnosed with IF Nasr, SH et al: The diagnosis and characteristics of renal heavy chain/light chain amyloidosis and comparison with renal light-chain amyloidosis. Kidney Int 2013; 83: 463-470

LIGHT / HEAVY CHAIN AMYLOIDOSIS (AL/AH) MORPHOLOGICAL DIFFERENCES WITH AL-AMYLOIDOSIS More hypercellularity in mesangial areas with amyloid deposition Strong PAS staining associated with amyloid deposits Silver staining in areas with amyloid deposition

EVEN C1q in selected cases MAY VARY FROM 10-90 NM FREQUENTLY PARALLEL TO EACH OTHER

IF- IgG

IMMUNOTACTOID GN MICROTUBULAR STRUCTURES CAN BE LONG AND GENERALLY ORGANIZED IN PARALLEL BUNDLES ORGANIZED MICROTUBULAR STRUCTURES WHICH MEASURE 30-50 NM IN WIDTH NEGATIVE FOR CONGO RED AND THIOFLAVIN T MAIN DIFFERENTIAL DX IS CRYOS

IMMUNOTACTOID GN EXTRARENAL DEPOSITS ARE EXTREMELY RARE SIMILAR ENTITY IN THE EYE- relationship to renal disease unclear Can be confused with cryoglobulinemic nephropathy as the deposits are microtubular not FIBRILLARY

DIABETIC FIBRILLOSIS Appearance of fibrils ultrastructurally identical to FIBRILLARY GN BUT FIBRILS ONLY IN MESANGIUM IF IS NEGATIVE FOR IgG / kappa / lambda (LINEAR IgG and albumin seen in DN) AND OCCURS IN THE SETTING OF NODULAR GLOMERULOSCLEROSIS

DIABETIC FIBRILLOSIS